Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves’ Disease Patients
Graves’ disease (GD) is hyperthyroidism associated with organ-specific autoimmune inflammation. GD occurs more frequently in adults than in children; however, pediatric patients are a therapeutic challenge due to cycles of remissions and relapses requiring constant monitoring at every stage of treat...
Main Authors: | Aleksandra Starosz, Karolina Stożek, Marcin Moniuszko, Kamil Grubczak, Artur Bossowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/2/164 |
Similar Items
-
Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
by: Eun Roh, et al.
Published: (2013-03-01) -
Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease
by: Sun Hee Lee, et al.
Published: (2013-03-01) -
Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
by: Hyun Gyung Lee, et al.
Published: (2021-09-01) -
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
by: Fereidoun Azizi, et al.
Published: (2021-04-01) -
Methimazole-Induced Leukocytoclastic Vasculitis: A Case Report
by: Weeratian Tawanwongsri, et al.
Published: (2019-11-01)